{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:53:27Z","timestamp":1792792407968,"version":"4.5.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03777-5","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:54:55Z","timestamp":1761044095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-591X","authenticated-orcid":false,"given":"Farzaneh","family":"Tavakoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad ali","family":"Araskhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8594-2950","authenticated-orcid":false,"given":"Fatemeh","family":"Karimpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-7613","authenticated-orcid":false,"given":"Hamed","family":"Soleimani Samarkhazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Hasheminasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-4342","authenticated-orcid":false,"given":"Elham","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0438-4438","authenticated-orcid":false,"given":"Nader","family":"Vazifeh Shiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dehghanifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4884-5218","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"24","key":"3777_CR1","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.21037\/atm-22-5520","volume":"10","author":"R Mi","year":"2022","unstructured":"Mi R, et al. A retrospective study on effectiveness of combined Recombinant human interferon-\u03b1-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease States. Ann Transl Med. 2022;10(24):1382.","journal-title":"Ann Transl Med"},{"issue":"34","key":"3777_CR2","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1200\/JCO.22.00181","volume":"40","author":"A Mishra","year":"2022","unstructured":"Mishra A, et al. Eprenetapopt plus Azacitidine after allogeneic hematopoietic Stem-Cell transplantation for TP53-Mutant acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2022;40(34):3985\u201393.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3777_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-025-00738-6","volume":"13","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, et al. Unveiling the potential of CLL-1: a promising target for AML therapy. Biomark Res. 2025;13(1):28.","journal-title":"Biomark Res"},{"key":"3777_CR4","doi-asserted-by":"crossref","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer, 2019. 19(7): pp. 405\u2013414.","DOI":"10.1038\/s41568-019-0149-1"},{"key":"3777_CR5","doi-asserted-by":"publisher","first-page":"637162","DOI":"10.3389\/fcell.2021.637162","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, et al. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol. 2021;9:637162.","journal-title":"Front Cell Dev Biol"},{"key":"3777_CR6","doi-asserted-by":"publisher","first-page":"104203","DOI":"10.1016\/j.critrevonc.2023.104203","volume":"193","author":"X Tang","year":"2024","unstructured":"Tang X, et al. Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy. Crit Rev Oncol Hematol. 2024;193:104203.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3777_CR7","doi-asserted-by":"publisher","first-page":"113662","DOI":"10.1016\/j.biopha.2022.113662","volume":"154","author":"E Catanzaro","year":"2022","unstructured":"Catanzaro E, et al. Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy. Biomed Pharmacother. 2022;154:113662.","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"3777_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.21037\/atm-21-3368","volume":"9","author":"J Wei","year":"2021","unstructured":"Wei J, et al. Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia. Ann Transl Med. 2021;9(17):1381.","journal-title":"Ann Transl Med"},{"key":"3777_CR9","doi-asserted-by":"publisher","first-page":"930654","DOI":"10.3389\/fonc.2022.930654","volume":"12","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, et al. Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: A bioinformatics analysis and experimental verification. Front Oncol. 2022;12:930654.","journal-title":"Front Oncol"},{"key":"3777_CR10","doi-asserted-by":"publisher","first-page":"155288","DOI":"10.1016\/j.phymed.2023.155288","volume":"124","author":"Z Chen","year":"2024","unstructured":"Chen Z, et al. Dual role of Nrf2\/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells. Phytomedicine. 2024;124:155288.","journal-title":"Phytomedicine"},{"issue":"4","key":"3777_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","volume":"38","author":"H Akiyama","year":"2024","unstructured":"Akiyama H, et al. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia. 2024;38(4):729\u201340.","journal-title":"Leukemia"},{"issue":"1","key":"3777_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/bloodadvances.2023010786","volume":"8","author":"A Cunningham","year":"2024","unstructured":"Cunningham A, et al. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia. Blood Adv. 2024;8(1):56\u201369.","journal-title":"Blood Adv"},{"issue":"3","key":"3777_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjh.18884","volume":"202","author":"Z Ma","year":"2023","unstructured":"Ma Z, et al. Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. Br J Haematol. 2023;202(3):566\u201377.","journal-title":"Br J Haematol"},{"issue":"6","key":"3777_CR14","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, et al. Cystine uptake Inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia. 2022;36(6):1585\u201395.","journal-title":"Leukemia"},{"issue":"7","key":"3777_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/2159-8290.CD-22-0411","volume":"13","author":"M Sabatier","year":"2023","unstructured":"Sabatier M, et al. C\/EBP\u03b1 confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative Stress-Induced ferroptosis in FLT3-Mutant leukemia. Cancer Discov. 2023;13(7):1720\u201347.","journal-title":"Cancer Discov"},{"issue":"8","key":"3777_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/cbf.3869","volume":"41","author":"X Shen","year":"2023","unstructured":"Shen X, et al. Targeted single-cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis-resistant state in hematologic malignancies. Cell Biochem Funct. 2023;41(8):1343\u201356.","journal-title":"Cell Biochem Funct"},{"key":"3777_CR17","doi-asserted-by":"publisher","first-page":"1308869","DOI":"10.3389\/fonc.2023.1308869","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Molecular mechanisms of ferroptosis and its roles in leukemia. Front Oncol. 2023;13:1308869.","journal-title":"Front Oncol"},{"issue":"4","key":"3777_CR18","doi-asserted-by":"publisher","first-page":"e1054549","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, et al. The ferroptosis inducer Erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4):e1054549.","journal-title":"Mol Cell Oncol"},{"issue":"6","key":"3777_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41565-019-0406-1","volume":"14","author":"V Trujillo-Alonso","year":"2019","unstructured":"Trujillo-Alonso V, et al. FDA-approved Ferumoxytol displays anti-leukaemia efficacy against cells with low Ferroportin levels. Nat Nanotechnol. 2019;14(6):616\u201322.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"3777_CR20","first-page":"467","volume":"20","author":"T Luo","year":"2022","unstructured":"Luo T, Wang Y, Wang J. Ferroptosis Assassinates Tumor J Nanobiotechnol. 2022;20(1):467.","journal-title":"Ferroptosis Assassinates Tumor J Nanobiotechnol"},{"issue":"1","key":"3777_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, et al. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3777_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2022","unstructured":"Birsen R, et al. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 2022;107(2):403\u201316.","journal-title":"Haematologica"},{"issue":"6","key":"3777_CR23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32(6):920\u201337.","journal-title":"Cell Metab"},{"key":"3777_CR24","doi-asserted-by":"publisher","first-page":"888570","DOI":"10.3389\/fonc.2022.888570","volume":"12","author":"FM Zhong","year":"2022","unstructured":"Zhong FM, et al. Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia. Front Oncol. 2022;12:888570.","journal-title":"Front Oncol"},{"issue":"1","key":"3777_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10238-025-01588-0","volume":"25","author":"A Raoufi","year":"2025","unstructured":"Raoufi A, et al. Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets. Clin Experimental Med. 2025;25(1):73.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"3777_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40164-023-00411-4","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Exp Hematol Oncol. 2023;12(1):47.","journal-title":"Exp Hematol Oncol"},{"key":"3777_CR27","doi-asserted-by":"crossref","unstructured":"Zheng X, Zhang C. The regulation of ferroptosis by noncoding RNAs. Int J Mol Sci, 2023. 24(17).","DOI":"10.3390\/ijms241713336"},{"issue":"1","key":"3777_CR28","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13(1):2206.","journal-title":"Nat Commun"},{"key":"3777_CR29","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther. 2023;244:108373.","journal-title":"Pharmacol Ther"},{"key":"3777_CR30","doi-asserted-by":"publisher","first-page":"586578","DOI":"10.3389\/fcell.2020.586578","volume":"8","author":"F Kuang","year":"2020","unstructured":"Kuang F, et al. Oxidative damage and antioxidant defense in ferroptosis. Front Cell Dev Biol. 2020;8:586578.","journal-title":"Front Cell Dev Biol"},{"key":"3777_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","volume":"131","author":"J Du","year":"2019","unstructured":"Du J, et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med. 2019;131:356\u201369.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"3777_CR32","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425\u20138.","journal-title":"Autophagy"},{"issue":"49","key":"3777_CR33","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, et al. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117(49):31189\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3777_CR34","doi-asserted-by":"publisher","first-page":"158093","DOI":"10.1016\/j.cej.2024.158093","volume":"503","author":"L Li","year":"2025","unstructured":"Li L, et al. Nanozyme-enhanced tyramine signal amplification probe for preamplification-free myocarditis-related MiRNAs detection. Chem Eng J. 2025;503:158093.","journal-title":"Chem Eng J"},{"key":"3777_CR35","doi-asserted-by":"crossref","unstructured":"Oliva EN et al. A systematic literature review of the relationship between serum ferritin and outcomes in myelodysplastic syndromes. J Clin Med, 2022. 11(3).","DOI":"10.3390\/jcm11030895"},{"issue":"2","key":"3777_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00277-018-3539-7","volume":"98","author":"AM Zeidan","year":"2019","unstructured":"Zeidan AM, et al. Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes. Ann Hematol. 2019;98(2):339\u201350.","journal-title":"Ann Hematol"},{"key":"3777_CR37","doi-asserted-by":"publisher","first-page":"743006","DOI":"10.3389\/fonc.2021.743006","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Huang Z, Peng H. Molecular mechanisms of ferroptosis and its roles in hematologic malignancies. Front Oncol. 2021;11:743006.","journal-title":"Front Oncol"},{"key":"3777_CR38","doi-asserted-by":"publisher","first-page":"1275774","DOI":"10.3389\/fmolb.2023.1275774","volume":"10","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies. Front Mol Biosci. 2023;10:1275774.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"3777_CR39","first-page":"28","volume":"11","author":"A Noroozi Aghide","year":"2016","unstructured":"Noroozi Aghide A, Soleimani Samarkhazan H, Ahmadnezhad M. Effect of Harmine alkaloid on the expression of P16 and DAPK in HL60 leukemia cell line. Paramedical Sci Military Health. 2016;11(3):28\u201333.","journal-title":"Paramedical Sci Military Health"},{"key":"3777_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume":"79","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ, et al. Targeting p53 for the treatment of cancer. Semin Cancer Biol. 2022;79:58\u201367.","journal-title":"Semin Cancer Biol"},{"key":"3777_CR41","doi-asserted-by":"publisher","first-page":"897791","DOI":"10.3389\/fphar.2022.897791","volume":"13","author":"X Lai","year":"2022","unstructured":"Lai X, et al. Honokiol induces ferroptosis by upregulating HMOX1 in acute myeloid leukemia cells. Front Pharmacol. 2022;13:897791.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3777_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1620\/tjem.237.163","volume":"237","author":"L Bi","year":"2015","unstructured":"Bi L, et al. Honokiol inhibits constitutive and inducible STAT3 signaling via PU.1-Induced SHP1 expression in acute myeloid leukemia cells. Tohoku J Exp Med. 2015;237(3):163\u201372.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"3777_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","volume":"5","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam C, et al. Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer. 2024;5(1):47\u201365.","journal-title":"Nat Cancer"},{"key":"3777_CR44","doi-asserted-by":"crossref","unstructured":"Shang Y, et al. Pregnane X receptor activation induces ferroptosis resistance through upregulation of FSP1. Mol Carcinog; 2025.","DOI":"10.1002\/mc.70016"},{"issue":"1","key":"3777_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-025-02394-8","volume":"24","author":"W Ye","year":"2025","unstructured":"Ye W, et al. NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis. Mol Cancer. 2025;24(1):201.","journal-title":"Mol Cancer"},{"issue":"1","key":"3777_CR46","doi-asserted-by":"publisher","first-page":"2495221","DOI":"10.1080\/16078454.2025.2495221","volume":"30","author":"S Chen","year":"2025","unstructured":"Chen S, et al. Shikonin promotes ferroptosis though NSUN2-mediated m5C methylation modification of TFRC in acute myelocytic leukemia. Hematology. 2025;30(1):2495221.","journal-title":"Hematology"},{"issue":"1","key":"3777_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov. 2024;10(1):35.","journal-title":"Cell Death Discov"},{"key":"3777_CR48","doi-asserted-by":"crossref","unstructured":"Liu X, et al. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Volume 12. Experimental Hematology & Oncology; 2023. p. 47. 1.","DOI":"10.1186\/s40164-023-00411-4"},{"issue":"1","key":"3777_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng S, et al. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Exp Hematol Oncol. 2024;13(1):19.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"3777_CR50","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3923\/ijp.2023.632.641","volume":"19","author":"Q Su","year":"2023","unstructured":"Su Q, et al. Dihydroartemisinin increases the sensitivity of acute myeloid leukemia cells to cytarabine via the Nrf2\/HO-1 Anti-Oxidant signaling pathway. IJP. 2023;19(5):632\u201341.","journal-title":"IJP"},{"issue":"4","key":"3777_CR51","first-page":"730","volume":"9","author":"F Ye","year":"2019","unstructured":"Ye F, et al. HMGB1 regulates erastin-induced ferroptosis via RAS-JNK\/p38 signaling in HL-60\/NRAS(Q61L) cells. Am J Cancer Res. 2019;9(4):730\u20139.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"3777_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00432-024-05753-y","volume":"150","author":"H Zheng","year":"2024","unstructured":"Zheng H, et al. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway. J Cancer Res Clin Oncol. 2024;150(5):231.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"3777_CR53","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1111\/cas.15875","volume":"114","author":"D Wang","year":"2023","unstructured":"Wang D, et al. Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3\/ALOX15 axis. Cancer Sci. 2023;114(8):3446\u201360.","journal-title":"Cancer Sci"},{"issue":"11","key":"3777_CR54","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1182\/blood.2019001808","volume":"136","author":"RZ Yusuf","year":"2020","unstructured":"Yusuf RZ, et al. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers. Blood. 2020;136(11):1303\u201316.","journal-title":"Blood"},{"key":"3777_CR55","doi-asserted-by":"publisher","first-page":"147515","DOI":"10.1016\/j.gene.2023.147515","volume":"876","author":"H Dong","year":"2023","unstructured":"Dong H, et al. Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity. Gene. 2023;876:147515.","journal-title":"Gene"},{"issue":"7","key":"3777_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14715\/cmb\/2023.69.7.21","volume":"69","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Resveratrol drives ferroptosis of acute myeloid leukemia cells through Hsa-miR-335-5p\/NFS1\/ GPX4 pathway in a ROS-dependent manner. Cell Mol Biol (Noisy-le-grand). 2023;69(7):131\u20137.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"7","key":"3777_CR57","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.trecan.2023.04.011","volume":"9","author":"H Lee","year":"2023","unstructured":"Lee H, Zhuang L, Gan B. Ferroptosis vulnerability in FLT3-mutant leukemia. Trends Cancer. 2023;9(7):524\u20135.","journal-title":"Trends Cancer"},{"issue":"1","key":"3777_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1182\/blood.2024024072","volume":"144","author":"N Hassan","year":"2024","unstructured":"Hassan N, et al. Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4\/HOXA9-dependent AML. Blood. 2024;144(1):84\u201398.","journal-title":"Blood"},{"issue":"4","key":"3777_CR59","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/med.22015","volume":"44","author":"X Palomer","year":"2024","unstructured":"Palomer X, et al. GADD45A: with or without you. Med Res Rev. 2024;44(4):1375\u2013403.","journal-title":"Med Res Rev"},{"key":"3777_CR60","doi-asserted-by":"publisher","first-page":"740884","DOI":"10.3389\/fcell.2021.740884","volume":"9","author":"T Zhu","year":"2021","unstructured":"Zhu T, et al. Autophagy regulates VDAC3 ubiquitination by FBXW7 to promote Erastin-Induced ferroptosis in acute lymphoblastic leukemia. Front Cell Dev Biol. 2021;9:740884.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3777_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-023-01371-8","volume":"9","author":"E Grignano","year":"2023","unstructured":"Grignano E, et al. Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and Metallothionein. Cell Death Discov. 2023;9(1):97.","journal-title":"Cell Death Discov"},{"issue":"4","key":"3777_CR62","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.bbrc.2019.06.070","volume":"516","author":"HY Zhu","year":"2019","unstructured":"Zhu HY, et al. Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy. Biochem Biophys Res Commun. 2019;516(4):1265\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 1","key":"3777_CR63","doi-asserted-by":"publisher","first-page":"129332","DOI":"10.1016\/j.ijbiomac.2024.129332","volume":"260","author":"H Yang","year":"2024","unstructured":"Yang H, et al. TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Macromol. 2024;260(Pt 1):129332.","journal-title":"Int J Biol Macromol"},{"key":"3777_CR64","doi-asserted-by":"crossref","unstructured":"Han P et al. Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3\/MDM2 cascade. Ann Hematol, 2024.","DOI":"10.1007\/s00277-024-06003-4"},{"key":"3777_CR65","doi-asserted-by":"publisher","first-page":"144889","DOI":"10.1016\/j.gene.2020.144889","volume":"755","author":"Y Du","year":"2020","unstructured":"Du Y, et al. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway. Gene. 2020;755:144889.","journal-title":"Gene"},{"issue":"1","key":"3777_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40659-019-0232-9","volume":"52","author":"Y Feng","year":"2019","unstructured":"Feng Y, et al. ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN\/PI3K\/AKT signaling pathway. Biol Res. 2019;52(1):26.","journal-title":"Biol Res"},{"issue":"41","key":"3777_CR67","doi-asserted-by":"publisher","first-page":"e35002","DOI":"10.1097\/MD.0000000000035002","volume":"102","author":"J Niu","year":"2023","unstructured":"Niu J, et al. Comparison with gastric cancer-associated genes reveals the role of ferroptosis-related genes in eosinophils of asthma patients: A bioinformatic study. Medicine. 2023;102(41):e35002.","journal-title":"Medicine"},{"issue":"3","key":"3777_CR68","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11418-024-01811-4","volume":"78","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K\/SREBP-1\/SCD1 axis and triggering of lipid peroxidation. J Nat Med. 2024;78(3):618\u201332.","journal-title":"J Nat Med"},{"issue":"1","key":"3777_CR69","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12885-024-12212-x","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang L, et al. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K\/AKT activation. BMC Cancer. 2024;24(1):497.","journal-title":"BMC Cancer"},{"issue":"1","key":"3777_CR70","doi-asserted-by":"publisher","first-page":"e3219","DOI":"10.1002\/hon.3219","volume":"42","author":"X Song","year":"2024","unstructured":"Song X, et al. PAQR3 facilitates the ferroptosis of diffuse large B-cell lymphoma via the regulation of LDLR-mediated PI3K\/AKT pathway. Hematol Oncol. 2024;42(1):e3219.","journal-title":"Hematol Oncol"},{"key":"3777_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2023.04.003","volume":"203","author":"Z Yin","year":"2023","unstructured":"Yin Z, et al. Targeting ABCB6 with nitidine chloride inhibits PI3K\/AKT signaling pathway to promote ferroptosis in multiple myeloma. Free Radic Biol Med. 2023;203:86\u2013101.","journal-title":"Free Radic Biol Med"},{"key":"3777_CR72","doi-asserted-by":"crossref","unstructured":"Nguyen TPM et al. Ferroptosis - a potential feature underlying neratinib-induced colonic epithelial injury. Cancer Chemother Pharmacol, 2024.","DOI":"10.1007\/s00280-024-04699-9"},{"issue":"1","key":"3777_CR73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13020-023-00808-7","volume":"18","author":"G Liu","year":"2023","unstructured":"Liu G, et al. Z-ligustilide preferentially caused mitochondrial dysfunction in AML HL-60 cells by activating nuclear receptors NUR77 and NOR1. Chin Med. 2023;18(1):123.","journal-title":"Chin Med"},{"key":"3777_CR74","doi-asserted-by":"publisher","first-page":"153448","DOI":"10.1016\/j.phymed.2020.153448","volume":"82","author":"C Wang","year":"2021","unstructured":"Wang C, et al. Z-Ligustilide selectively targets AML by restoring nuclear receptors Nur77 and NOR-1-mediated apoptosis and differentiation. Phytomedicine. 2021;82:153448.","journal-title":"Phytomedicine"},{"issue":"17","key":"3777_CR75","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1021\/acs.jmedchem.9b00814","volume":"62","author":"J Sagasser","year":"2019","unstructured":"Sagasser J, et al. A new approach in cancer treatment: discovery of Chlorido[N,N\u2019-disalicylidene-1,2-phenylenediamine]iron(III) complexes as ferroptosis inducers. J Med Chem. 2019;62(17):8053\u201361.","journal-title":"J Med Chem"},{"key":"3777_CR76","doi-asserted-by":"crossref","unstructured":"Catanzaro E, et al. Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy. Volume 154. Biomedicine & Pharmacotherapy; 2022. p. 113662.","DOI":"10.1016\/j.biopha.2022.113662"},{"key":"3777_CR77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2024.01.005","volume":"213","author":"Y Wei","year":"2024","unstructured":"Wei Y, et al. Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity. Free Radic Biol Med. 2024;213:36\u201351.","journal-title":"Free Radic Biol Med"},{"key":"3777_CR78","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.actbio.2022.07.055","volume":"151","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy. Acta Biomater. 2022;151:480\u201390.","journal-title":"Acta Biomater"},{"issue":"2","key":"3777_CR79","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1039\/D3BM01832F","volume":"12","author":"N Xiao","year":"2024","unstructured":"Xiao N, et al. Recent progress in biomaterials-driven ferroptosis for cancer therapy. Biomater Sci. 2024;12(2):288\u2013307.","journal-title":"Biomater Sci"},{"key":"3777_CR80","doi-asserted-by":"publisher","first-page":"137829","DOI":"10.1016\/j.jcis.2025.137829","volume":"696","author":"Z Xu","year":"2025","unstructured":"Xu Z, et al. Cyclized polyacrylonitrile nanoparticles: enhanced intratumoral delivery by photocatalysis and collagen denaturation. J Colloid Interface Sci. 2025;696:137829.","journal-title":"J Colloid Interface Sci"},{"key":"3777_CR81","doi-asserted-by":"publisher","first-page":"137979","DOI":"10.1016\/j.jcis.2025.137979","volume":"697","author":"M Yu","year":"2025","unstructured":"Yu M, et al. Apigenin and doxorubicin loaded zeolitic imidazole frameworks for triple-combination therapy of breast cancer. J Colloid Interface Sci. 2025;697:137979.","journal-title":"J Colloid Interface Sci"},{"key":"3777_CR82","doi-asserted-by":"publisher","first-page":"1330910","DOI":"10.3389\/fphar.2023.1330910","volume":"14","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li X, Xu Y. Ferroptosis: a dual-edged sword in tumour growth. Front Pharmacol. 2024;14:1330910.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3777_CR83","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/09205063.2023.2294541","volume":"35","author":"G Janani","year":"2024","unstructured":"Janani G, Girigoswami A, Girigoswami K. Advantages of nanomedicine over the conventional treatment in acute myeloid leukemia. J Biomater Sci Polym Ed. 2024;35(3):415\u201341.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"4","key":"3777_CR84","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1021\/acsnano.2c06313","volume":"17","author":"Y Yu","year":"2023","unstructured":"Yu Y, et al. A Ferroptosis-Inducing and leukemic Cell-Targeting drug nanocarrier formed by Redox-Responsive cysteine polymer for acute myeloid leukemia therapy. ACS Nano. 2023;17(4):3334\u201345.","journal-title":"ACS Nano"},{"issue":"13","key":"3777_CR85","doi-asserted-by":"publisher","first-page":"e2106558","DOI":"10.1002\/smll.202106558","volume":"18","author":"K Cao","year":"2022","unstructured":"Cao K, et al. Glutathione-Bioimprinted nanoparticles targeting of N6-methyladenosine FTO demethylase as a strategy against leukemic stem cells. Small. 2022;18(13):e2106558.","journal-title":"Small"},{"issue":"1","key":"3777_CR86","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10238-025-01724-w","volume":"25","author":"A Bayani","year":"2025","unstructured":"Bayani A, et al. Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy. Clin Experimental Med. 2025;25(1):186.","journal-title":"Clin Experimental Med"},{"key":"3777_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.actbio.2022.03.030","volume":"144","author":"Q Li","year":"2022","unstructured":"Li Q, et al. Glycyrrhetinic acid nanoparticles combined with ferrotherapy for improved cancer immunotherapy. Acta Biomater. 2022;144:109\u201320.","journal-title":"Acta Biomater"},{"issue":"11","key":"3777_CR88","doi-asserted-by":"publisher","first-page":"17689","DOI":"10.1021\/acsnano.1c05547","volume":"15","author":"Y Du","year":"2021","unstructured":"Du Y, et al. Gold nanorods exhibit intrinsic therapeutic activity via controlling N6-Methyladenosine-Based epitranscriptomics in acute myeloid leukemia. ACS Nano. 2021;15(11):17689\u2013704.","journal-title":"ACS Nano"},{"issue":"12","key":"3777_CR89","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.3934\/mbe.2022551","volume":"19","author":"X Guo","year":"2022","unstructured":"Guo X, Zhou X. Risk stratification of acute myeloid leukemia: assessment using a novel prediction model based on ferroptosis-immune related genes. Math Biosci Eng. 2022;19(12):11821\u201339.","journal-title":"Math Biosci Eng"},{"key":"3777_CR90","doi-asserted-by":"publisher","first-page":"127517","DOI":"10.1016\/j.jtemb.2024.127517","volume":"86","author":"M Wu","year":"2024","unstructured":"Wu M, et al. The novel prognostic analysis of AML based on ferroptosis and Cuproptosis related genes. J Trace Elem Med Biol. 2024;86:127517.","journal-title":"J Trace Elem Med Biol"},{"key":"3777_CR91","doi-asserted-by":"crossref","unstructured":"Aval OS, et al. Galectin-9: A double-edged sword in acute myeloid leukemia. Annals of Hematology; 2025.","DOI":"10.1007\/s00277-025-06387-x"},{"issue":"1","key":"3777_CR92","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12672-024-01150-6","volume":"15","author":"Y Song","year":"2024","unstructured":"Song Y, et al. MICAL1 promotes the proliferation in acute myeloid leukemia and is associated with clinical prognosis and immune infiltration. Discov Oncol. 2024;15(1):279.","journal-title":"Discov Oncol"},{"key":"3777_CR93","doi-asserted-by":"publisher","first-page":"113392","DOI":"10.1016\/j.intimp.2024.113392","volume":"144","author":"D-Y Sun","year":"2025","unstructured":"Sun D-Y, et al. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies. Int Immunopharmacol. 2025;144:113392.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"3777_CR94","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.21037\/tcr-22-985","volume":"11","author":"P Ke","year":"2022","unstructured":"Ke P, et al. LPCAT3 is a potential prognostic biomarker and May be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis. Transl Cancer Res. 2022;11(10):3491\u2013505.","journal-title":"Transl Cancer Res"},{"key":"3777_CR95","doi-asserted-by":"crossref","unstructured":"Aghayan AH et al. Extracellular Vesicle-Based biomarkers in diffuse large B-Cell lymphoma: A systematic review and Meta-Analysis. Crit Rev Oncol\/Hematol, 2025: p. 104884.","DOI":"10.1016\/j.critrevonc.2025.104884"},{"issue":"4","key":"3777_CR96","first-page":"608","volume":"22","author":"X Huang","year":"2022","unstructured":"Huang X, et al. A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia. Bosn J Basic Med Sci. 2022;22(4):608\u201328.","journal-title":"Bosn J Basic Med Sci"},{"key":"3777_CR97","doi-asserted-by":"crossref","unstructured":"Yan XS et al. Effects of ferroptosis-related gene HSPB1 on acute myeloid leukemia. Int J Lab Hematol, 2024.","DOI":"10.1111\/ijlh.14319"},{"key":"3777_CR98","doi-asserted-by":"publisher","first-page":"1281141","DOI":"10.3389\/fmolb.2023.1281141","volume":"10","author":"F Wu","year":"2023","unstructured":"Wu F, et al. A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia. Front Mol Biosci. 2023;10:1281141.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"3777_CR99","doi-asserted-by":"publisher","first-page":"e28237","DOI":"10.1016\/j.heliyon.2024.e28237","volume":"10","author":"L Jing","year":"2024","unstructured":"Jing L, et al. Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature. Heliyon. 2024;10(6):e28237.","journal-title":"Heliyon"},{"issue":"16","key":"3777_CR100","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.18632\/aging.206068","volume":"16","author":"C Wang","year":"2024","unstructured":"Wang C, et al. Identification of immunity- and ferroptosis-related signature genes as potential design targets for mRNA vaccines in AML patients. Aging. 2024;16(16):11939\u201354.","journal-title":"Aging"},{"key":"3777_CR101","first-page":"p","volume":"104912","author":"F Zhang","year":"2025","unstructured":"Zhang F, et al. Beyond CAR-T: engineered NK cell therapies (CAR-NK, NKCEs) in Next-Generation cancer immunotherapy. Crit Rev Oncol\/Hematol. 2025;104912:p.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"3777_CR102","doi-asserted-by":"publisher","first-page":"800267","DOI":"10.3389\/fcell.2021.800267","volume":"9","author":"J Wang","year":"2021","unstructured":"Wang J, et al. Identification and validation of a prognostic Risk-Scoring model based on Ferroptosis-Associated cluster in acute myeloid leukemia. Front Cell Dev Biol. 2021;9:800267.","journal-title":"Front Cell Dev Biol"},{"key":"3777_CR103","doi-asserted-by":"publisher","first-page":"1149513","DOI":"10.3389\/fimmu.2023.1149513","volume":"14","author":"G Jiang","year":"2023","unstructured":"Jiang G, et al. Identification and validation of a novel CD8\u2009+\u2009T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia. Front Immunol. 2023;14:1149513.","journal-title":"Front Immunol"},{"key":"3777_CR104","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.2147\/IJGM.S460164","volume":"17","author":"Y Hong","year":"2024","unstructured":"Hong Y, et al. Ferroptosis-Related gene signature for prognosis prediction in acute myeloid leukemia and potential therapeutic options. Int J Gen Med. 2024;17:3837\u201353.","journal-title":"Int J Gen Med"},{"key":"3777_CR105","doi-asserted-by":"publisher","first-page":"1207642","DOI":"10.3389\/fcell.2023.1207642","volume":"11","author":"D Fu","year":"2023","unstructured":"Fu D, et al. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and Deciphers the immune microenvironment. Front Cell Dev Biology. 2023;11:1207642.","journal-title":"Front Cell Dev Biology"},{"issue":"23","key":"3777_CR106","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1111\/jcmm.17013","volume":"25","author":"R Shao","year":"2021","unstructured":"Shao R, et al. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia. J Cell Mol Med. 2021;25(23):10950\u201360.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3777_CR107","doi-asserted-by":"publisher","first-page":"17874","DOI":"10.1038\/s41598-024-68755-3","volume":"14","author":"Y Qin","year":"2024","unstructured":"Qin Y, et al. Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns. Sci Rep. 2024;14(1):17874.","journal-title":"Sci Rep"},{"key":"3777_CR108","doi-asserted-by":"crossref","unstructured":"Pitts HA et al. SPINK2 protein expression is an independent adverse prognostic marker in AML and is potentially implicated in the regulation of ferroptosis and immune response. Int J Mol Sci, 2023. 24(11).","DOI":"10.3390\/ijms24119696"},{"issue":"1","key":"3777_CR109","first-page":"197","volume":"14","author":"X Chen","year":"2022","unstructured":"Chen X, et al. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia. Am J Transl Res. 2022;14(1):197\u2013210.","journal-title":"Am J Transl Res"},{"issue":"1","key":"3777_CR110","first-page":"92","volume":"4","author":"S Gezer","year":"2023","unstructured":"Gezer S, et al. Upregulation of SPINK2 in acute myeloid leukemia. Adv Lab Med. 2023;4(1):92\u2013104.","journal-title":"Adv Lab Med"},{"issue":"11","key":"3777_CR111","doi-asserted-by":"publisher","first-page":"678","DOI":"10.21037\/atm-20-3296","volume":"8","author":"J Wei","year":"2020","unstructured":"Wei J, et al. Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia. Ann Transl Med. 2020;8(11):678.","journal-title":"Ann Transl Med"},{"key":"3777_CR112","doi-asserted-by":"publisher","first-page":"708699","DOI":"10.3389\/fgene.2021.708699","volume":"12","author":"Y Song","year":"2022","unstructured":"Song Y, et al. Construction and validation of a novel ferroptosis-related prognostic model for acute myeloid leukemia. Front Genet. 2022;12:708699.","journal-title":"Front Genet"},{"key":"3777_CR113","doi-asserted-by":"publisher","first-page":"748925","DOI":"10.3389\/fcell.2021.748925","volume":"9","author":"ZZ Shi","year":"2021","unstructured":"Shi ZZ, et al. Prognostic and immunological role of key genes of ferroptosis in Pan-Cancer. Front Cell Dev Biol. 2021;9:748925.","journal-title":"Front Cell Dev Biol"},{"key":"3777_CR114","doi-asserted-by":"publisher","first-page":"866325","DOI":"10.3389\/fphar.2022.866325","volume":"13","author":"Z Cui","year":"2022","unstructured":"Cui Z, et al. Comprehensive analysis of a ferroptosis pattern and associated prognostic signature in acute myeloid leukemia. Front Pharmacol. 2022;13:866325.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3777_CR115","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/16078454.2021.1996055","volume":"26","author":"F Zhou","year":"2021","unstructured":"Zhou F, Chen B. Prognostic significance of ferroptosis-related genes and their methylation in AML. Hematology. 2021;26(1):919\u201330.","journal-title":"Hematology"},{"key":"3777_CR116","doi-asserted-by":"publisher","first-page":"1068094","DOI":"10.3389\/fonc.2022.1068094","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia. Front Oncol. 2022;12:1068094.","journal-title":"Front Oncol"},{"key":"3777_CR117","doi-asserted-by":"publisher","first-page":"684396","DOI":"10.3389\/fonc.2021.684396","volume":"11","author":"G Simonetti","year":"2021","unstructured":"Simonetti G, et al. Adrenomedullin expression characterizes leukemia stem cells and associates with an inflammatory signature in acute myeloid leukemia. Front Oncol. 2021;11:684396.","journal-title":"Front Oncol"},{"issue":"8","key":"3777_CR118","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/mc.23550","volume":"62","author":"L Zhou","year":"2023","unstructured":"Zhou L, et al. PRMT1 Inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia. Mol Carcinog. 2023;62(8):1119\u201335.","journal-title":"Mol Carcinog"},{"key":"3777_CR119","doi-asserted-by":"publisher","first-page":"849437","DOI":"10.3389\/fgene.2022.849437","volume":"13","author":"C Han","year":"2022","unstructured":"Han C, et al. Novel prognostic signature for acute myeloid leukemia: bioinformatics analysis of combined CNV-Driven and Ferroptosis-Related genes. Front Genet. 2022;13:849437.","journal-title":"Front Genet"},{"issue":"24","key":"3777_CR120","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1002\/cam4.4806","volume":"11","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia. Cancer Med. 2022;11(24):5050\u201365.","journal-title":"Cancer Med"},{"key":"3777_CR121","doi-asserted-by":"crossref","unstructured":"Kong Q et al. Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1\/ACSL4 pathway. Int J Oncol, 2025. 66(1).","DOI":"10.3892\/ijo.2024.5708"},{"issue":"1","key":"3777_CR122","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s40001-024-01822-7","volume":"29","author":"MH Ashoub","year":"2024","unstructured":"Ashoub MH, et al. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology. Eur J Med Res. 2024;29(1):224.","journal-title":"Eur J Med Res"},{"issue":"1","key":"3777_CR123","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1038\/s41467-021-25632-1","volume":"12","author":"J Gao","year":"2021","unstructured":"Gao J, Luo T, Wang J. Gene interfered-ferroptosis therapy for cancers. Nat Commun. 2021;12(1):5311.","journal-title":"Nat Commun"},{"key":"3777_CR124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2025.03.031","volume":"233","author":"J Shi","year":"2025","unstructured":"Shi J, et al. SR-B1 deficiency suppresses progression in acute myeloid leukemia via ferroptosis and reverses resistance to venetoclax. Free Radic Biol Med. 2025;233:24\u201338.","journal-title":"Free Radic Biol Med"},{"key":"3777_CR125","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.2147\/IJN.S509007","volume":"20","author":"W Wang","year":"2025","unstructured":"Wang W, et al. Mechanism of a novel complex: zinc oxide Nanoparticles-Luteolin to promote ferroptosis in human acute myeloid leukemia cells in vitro. Int J Nanomed. 2025;20:4035\u201350.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3777_CR126","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discovery. 2024;10(1):35.","journal-title":"Cell Death Discovery"},{"issue":"14","key":"3777_CR127","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1200\/JCO.20.02342","volume":"39","author":"T Cluzeau","year":"2021","unstructured":"Cluzeau T, et al. Eprenetapopt plus Azacitidine in TP53-Mutated myelodysplastic syndromes and acute myeloid leukemia: A phase II study by the groupe Francophone des My\u00e9lodysplasies (GFM). J Clin Oncol. 2021;39(14):1575\u201383.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3777_CR128","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3324\/haematol.2019.230482","volume":"105","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia. Haematologica. 2020;105(9):2286\u201397.","journal-title":"Haematologica"},{"issue":"4","key":"3777_CR129","doi-asserted-by":"publisher","first-page":"155932581988704","DOI":"10.1177\/1559325819887048","volume":"17","author":"X Huang","year":"2019","unstructured":"Huang X, et al. Targeting approaches of nanomedicines in acute myeloid leukemia. Dose-Response. 2019;17(4):1559325819887048.","journal-title":"Dose-Response"},{"key":"3777_CR130","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S466042","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Tumor Cell-Targeting and tumor Microenvironment-Responsive nanoplatforms for the multimodal Imaging-Guided Photodynamic\/Photothermal\/Chemodynamic treatment of cervical cancer. Int J Nanomed. 2024;19:5837\u201358.","journal-title":"Int J Nanomed"},{"issue":"2","key":"3777_CR131","first-page":"20210238","volume":"2","author":"D Jana","year":"2022","unstructured":"Jana D, Zhao Y. Strategies for enhancing cancer chemodynamic therapy performance. Explor (Beijing). 2022;2(2):20210238.","journal-title":"Explor (Beijing)"},{"issue":"1","key":"3777_CR132","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10238-025-01764-2","volume":"25","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, et al. Targeting acute myeloid leukemia through antibody engineering: innovations in immunotherapy and combination regimens. Clin Experimental Med. 2025;25(1):215.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"3777_CR133","first-page":"1","volume":"3","author":"M Farrokhi","year":"2023","unstructured":"Farrokhi M, et al. Role of precision medicine and personalized medicine in the treatment of diseases. Kindle. 2023;3(1):1\u2013164.","journal-title":"Kindle"},{"issue":"1","key":"3777_CR134","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10238-025-01686-z","volume":"25","author":"AK Bishoyi","year":"2025","unstructured":"Bishoyi AK, et al. Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation. Clin Experimental Med. 2025;25(1):166.","journal-title":"Clin Experimental Med"},{"key":"3777_CR135","unstructured":"Soleimani Samarkhazan H et al. Nanosensors in Leukemia Management: Pioneering Real-Time Biomarker Detection for Precision Oncology. Nano Select. n\/a(n\/a): p. e70039."},{"issue":"1","key":"3777_CR136","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1002\/mog2.67","volume":"3","author":"X Huang","year":"2024","unstructured":"Huang X, et al. Advances and applications of nanoparticles in cancer therapy. MedComm \u2013 Oncol. 2024;3(1):e67.","journal-title":"MedComm \u2013 Oncol"},{"issue":"1","key":"3777_CR137","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10238-025-01795-9","volume":"25","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, et al. The AML immune paradox: decoding escape pathways and pioneering checkpoint, vaccine, and combination strategies. Clin Exp Med. 2025;25(1):240.","journal-title":"Clin Exp Med"},{"key":"3777_CR138","doi-asserted-by":"crossref","unstructured":"Zhong SJ et al. Peptide blockers of PD-1-PD-L1 interaction reinvigorate PD-1-Suppressed T cells and curb tumor growth in mice. Cells, 2024. 13(14).","DOI":"10.3390\/cells13141193"},{"issue":"3","key":"3777_CR139","first-page":"358","volume":"4","author":"X Wang","year":"2025","unstructured":"Wang X, et al. Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance. Acta Materia Med. 2025;4(3):358\u201389.","journal-title":"Acta Materia Med"},{"key":"3777_CR140","doi-asserted-by":"crossref","unstructured":"You W et al. From foe to friend: rewiring oncogenic pathways through artificial Selenoprotein to combat immune-resistant tumor. J Pharm Anal, 2025: p. 101322.","DOI":"10.1016\/j.jpha.2025.101322"},{"key":"3777_CR141","doi-asserted-by":"publisher","first-page":"954524","DOI":"10.3389\/fmolb.2022.954524","volume":"9","author":"Y Tao","year":"2022","unstructured":"Tao Y, Wei L, You H. Ferroptosis-related gene signature predicts the clinical outcome in pediatric acute myeloid leukemia patients and refines the 2017 ELN classification system. Front Mol Biosci. 2022;9:954524.","journal-title":"Front Mol Biosci"},{"key":"3777_CR142","doi-asserted-by":"publisher","first-page":"1207642","DOI":"10.3389\/fcell.2023.1207642","volume":"11","author":"D Fu","year":"2023","unstructured":"Fu D, et al. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and Deciphers the immune microenvironment. Front Cell Dev Biol. 2023;11:1207642.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3777_CR143","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10238-025-01783-z","volume":"25","author":"M Abdar Esfahani","year":"2025","unstructured":"Abdar Esfahani M, et al. The epigenetic revolution in hematology: from benchside breakthroughs to clinical transformations. Clin Experimental Med. 2025;25(1):230.","journal-title":"Clin Experimental Med"},{"issue":"6","key":"3777_CR144","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/biomedicines13061375","volume":"13","author":"S Xu","year":"2025","unstructured":"Xu S, et al. Mechanism of circadian regulation in ferroptosis of the BMAL1\/NRF2 pathway in renal Ischemia\u2013Reperfusion. Biomedicines. 2025;13(6):1375.","journal-title":"Biomedicines"},{"issue":"11","key":"3777_CR145","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1080\/15548627.2019.1659623","volume":"15","author":"J Liu","year":"2019","unstructured":"Liu J, et al. Autophagic degradation of the circadian clock regulator promotes ferroptosis. Autophagy. 2019;15(11):2033\u20135.","journal-title":"Autophagy"},{"key":"3777_CR146","doi-asserted-by":"publisher","first-page":"116115","DOI":"10.1016\/j.biopha.2023.116115","volume":"171","author":"N Liu","year":"2024","unstructured":"Liu N, Chen M. Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application. Biomed Pharmacother. 2024;171:116115.","journal-title":"Biomed Pharmacother"},{"key":"3777_CR147","doi-asserted-by":"crossref","unstructured":"Xu S et al. Mechanism of circadian regulation in ferroptosis of the BMAL1\/NRF2 pathway in renal Ischemia-Reperfusion. Biomedicines, 2025. 13(6).","DOI":"10.3390\/biomedicines13061375"},{"issue":"1","key":"3777_CR148","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Therapy. 2024;9(1):55.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"3777_CR149","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"issue":"1","key":"3777_CR150","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","volume":"17","author":"F Chen","year":"2024","unstructured":"Chen F, et al. Ferroptosis: principles and significance in health and disease. J Hematol Oncol. 2024;17(1):41.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"3777_CR151","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40139-017-0139-5","volume":"5","author":"R Kang","year":"2017","unstructured":"Kang R, Tang D. Autophagy and Ferroptosis - What\u2019s the connection? Curr Pathobiol Rep. 2017;5(2):153\u20139.","journal-title":"Curr Pathobiol Rep"},{"key":"3777_CR152","doi-asserted-by":"publisher","first-page":"111583","DOI":"10.1016\/j.cellsig.2024.111583","volume":"127","author":"R Bian","year":"2025","unstructured":"Bian R, et al. HDAC inhibitor enhances ferroptosis susceptibility of AML cells by stimulating iron metabolism. Cell Signal. 2025;127:111583.","journal-title":"Cell Signal"},{"issue":"23","key":"3777_CR153","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-24-0796","volume":"30","author":"H Zhou","year":"2024","unstructured":"Zhou H, et al. Combinations of HDAC inhibitor and PPAR agonist induce ferroptosis of leukemic stem Cell-like cells in acute myeloid leukemia. Clin Cancer Res. 2024;30(23):5430\u201344.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3777_CR154","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1021\/acs.jmedchem.4c02550","volume":"68","author":"M Yang","year":"2025","unstructured":"Yang M, et al. HDAC11 Inhibition as a potential therapeutic strategy for AML: target Identification, lead Discovery, antitumor Potency, and mechanism investigation. J Med Chem. 2025;68(8):8124\u201342.","journal-title":"J Med Chem"},{"issue":"12","key":"3777_CR155","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, et al. Immunogenic cell death and damps in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"3777_CR156","doi-asserted-by":"crossref","unstructured":"Zahran AM et al. Disturbed expression of memory T-Cell subsets could alter the outcomes in adult acute myeloid leukemia. EJMO, 2023. 7(4).","DOI":"10.14744\/ejmo.2023.35138"},{"issue":"7939","key":"3777_CR157","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612(7939):338\u201346.","journal-title":"Nature"},{"issue":"3","key":"3777_CR158","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/ctm2.70253","volume":"15","author":"X Xia","year":"2025","unstructured":"Xia X, et al. Ferroptosis of T cell in inflammation and tumour immunity. Clin Transl Med. 2025;15(3):e70253.","journal-title":"Clin Transl Med"},{"issue":"1","key":"3777_CR159","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11033-025-10527-x","volume":"52","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, et al. C-type lectin-like molecule-1 as a diagnostic, prognostic, and therapeutic marker in leukemia. Mol Biol Rep. 2025;52(1):464.","journal-title":"Mol Biol Rep"},{"key":"3777_CR160","doi-asserted-by":"crossref","unstructured":"Fu D et al. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and Deciphers the immune microenvironment. Front Cell Dev Biology, 2023. Volume 11\u20132023.","DOI":"10.3389\/fcell.2023.1207642"},{"key":"3777_CR161","doi-asserted-by":"crossref","unstructured":"Zhong F-M et al. Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia. Front Oncol, 2022. Volume 12\u20132022.","DOI":"10.3389\/fonc.2022.888570"},{"issue":"59","key":"3777_CR162","doi-asserted-by":"publisher","first-page":"35753","DOI":"10.1039\/D0RA05901C","volume":"10","author":"US Gaharwar","year":"2020","unstructured":"Gaharwar US, Kumar S, Rajamani P. Iron oxide nanoparticle-induced hematopoietic and immunological response in rats. RSC Adv. 2020;10(59):35753\u201364.","journal-title":"RSC Adv"},{"issue":"5","key":"3777_CR163","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.leukres.2006.08.006","volume":"31","author":"EB Garon","year":"2007","unstructured":"Garon EB, et al. Quantum Dot labeling and tracking of human leukemic, bone marrow and cord blood cells. Leuk Res. 2007;31(5):643\u201351.","journal-title":"Leuk Res"},{"issue":"9","key":"3777_CR164","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","volume":"31","author":"C Zhou","year":"2024","unstructured":"Zhou C, et al. Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. Cell Stem Cell. 2024;31(9):1359\u2013e13758.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3777_CR165","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1039\/C8TX00248G","volume":"8","author":"V Kalyanaraman","year":"2019","unstructured":"Kalyanaraman V, et al. Biocompatibility studies on cerium oxide nanoparticles \u2013 combined study for local effects, systemic toxicity and genotoxicity via implantation route. Toxicol Res. 2019;8(1):25\u201337.","journal-title":"Toxicol Res"},{"issue":"1","key":"3777_CR166","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12951-024-02842-5","volume":"22","author":"S Han","year":"2024","unstructured":"Han S, et al. Nanobiotechnology boosts ferroptosis: opportunities and challenges. J Nanobiotechnol. 2024;22(1):606.","journal-title":"J Nanobiotechnol"},{"key":"3777_CR167","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-0716-3433-2_6","volume":"2712","author":"Z Dai","year":"2023","unstructured":"Dai Z, et al. Probing lipid peroxidation in ferroptosis: emphasizing the utilization of C11-BODIPY-Based protocols. Methods Mol Biol. 2023;2712:61\u201372.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3777_CR168","doi-asserted-by":"publisher","first-page":"e23507","DOI":"10.1016\/j.heliyon.2023.e23507","volume":"10","author":"Z Chen","year":"2024","unstructured":"Chen Z, et al. The application of approaches in detecting ferroptosis. Heliyon. 2024;10(1):e23507.","journal-title":"Heliyon"},{"issue":"1","key":"3777_CR169","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40364-025-00786-y","volume":"13","author":"S Zehtabcheh","year":"2025","unstructured":"Zehtabcheh S, et al. Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies. Biomark Res. 2025;13(1):73.","journal-title":"Biomark Res"},{"issue":"6","key":"3777_CR170","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","volume":"111","author":"A Sallmyr","year":"2008","unstructured":"Sallmyr A, et al. Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood. 2008;111(6):3173\u201382.","journal-title":"Blood"},{"issue":"10","key":"3777_CR171","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41419-019-1984-4","volume":"10","author":"T-X Wang","year":"2019","unstructured":"Wang T-X, et al. The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis. Cell Death Dis. 2019;10(10):755.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3777_CR172","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","volume":"175","author":"SK McBrayer","year":"2018","unstructured":"McBrayer SK, et al. Transaminase Inhibition by 2-Hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma. Cell. 2018;175(1):101\u2013e11625.","journal-title":"Cell"},{"issue":"1","key":"3777_CR173","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1002\/mog2.70","volume":"3","author":"M Ge","year":"2024","unstructured":"Ge M, et al. The biological essence of synthetic lethality: bringing new opportunities for cancer therapy. MedComm \u2013 Oncol. 2024;3(1):e70.","journal-title":"MedComm \u2013 Oncol"},{"key":"3777_CR174","doi-asserted-by":"crossref","unstructured":"Kannan S et al. Targeting the NRF2\/HO-1 antioxidant pathway in FLT3-ITD-Positive AML enhances therapy efficacy. Antioxid (Basel), 2022. 11(4).","DOI":"10.3390\/antiox11040717"},{"issue":"18","key":"3777_CR175","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.3390\/cancers16183210","volume":"16","author":"A Mohapatra","year":"2024","unstructured":"Mohapatra A, Mohanty A, Park I-K. Inorganic Nanomedicine\u2014Mediated ferroptosis: A synergistic approach to combined cancer therapies and immunotherapy. Cancers. 2024;16(18):3210.","journal-title":"Cancers"},{"issue":"17","key":"3777_CR176","doi-asserted-by":"publisher","first-page":"21546","DOI":"10.1021\/acsami.4c00793","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Oxygen-Independent radiodynamic therapy: Radiation-Boosted chemodynamics for reprogramming the tumor immune environment and enhancing antitumor immune response. ACS Appl Mater Interfaces. 2024;16(17):21546\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"3777_CR177","doi-asserted-by":"publisher","first-page":"2306580","DOI":"10.1002\/advs.202306580","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Cell death pathway regulation by functional nanomedicines for robust antitumor immunity. Adv Sci. 2024;11(3):2306580.","journal-title":"Adv Sci"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03777-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03777-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03777-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:05:22Z","timestamp":1761087922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03777-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03777-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1937"}}